4.5 Article

Pericyte-derived Glial Cell Line-derived Neurotrophic Factor Increase the Expression of Claudin-5 in the Blood-brain Barrier and the Blood-nerve Barrier

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

The blood-brain barrier, chemokines and multiple sclerosis

David W. Holman et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)

Article Biochemistry & Molecular Biology

Hydrocortisone Enhances the Function of the Blood-Nerve Barrier Through the Up-Regulation of Claudin-5

Yoko Kashiwamura et al.

NEUROCHEMICAL RESEARCH (2011)

Article Multidisciplinary Sciences

VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

Azeb Tadesse Argaw et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Clinical Neurology

Blood brain barrier in hypoxic-ischemic conditions

C. Kaur et al.

CURRENT NEUROVASCULAR RESEARCH (2008)

Review Geriatrics & Gerontology

Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats

A. Pertusa et al.

NEUROBIOLOGY OF AGING (2008)

Article Biochemical Research Methods

Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy

Elizabeth E. Capowski et al.

JOURNAL OF NEUROSCIENCE METHODS (2007)

Article Cell Biology

PPARγ-regulated tight junction development during human urothelial cytodifferentiation

Claire L. Varley et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2006)

Article Gastroenterology & Hepatology

Expression of angiopoietins, Tie2 and vascular endothelial growth factor in anglogenesis and progression of hepatocellular carcinoma

Zhong-Lin Zhang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2006)

Review Biotechnology & Applied Microbiology

Lentiviral vectors for use in the central nervous system

J Jakobsson et al.

MOLECULAR THERAPY (2006)

Article Cell Biology

Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5

Masaru Honda et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)

Article Clinical Neurology

Crossroads in GDNF therapy for Parkinson's disease

TB Sherer et al.

MOVEMENT DISORDERS (2006)

Review Biotechnology & Applied Microbiology

Lentivirus-mediated gene transfer to the central nervous system: Therapeutic and research applications

LF Wong et al.

HUMAN GENE THERAPY (2006)

Article Medicine, Research & Experimental

P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model

JR Cirrito et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)

Article Biotechnology & Applied Microbiology

GDNF delivery using human neural progenitor cells in a rat model of ALS

SM Klein et al.

HUMAN GENE THERAPY (2005)

Article Clinical Neurology

Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1

T Kanda et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)

Article Cell Biology

Novel functions and signalling pathways for GDNF

H Sariola et al.

JOURNAL OF CELL SCIENCE (2003)

Article Cell Biology

Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice

T Nitta et al.

JOURNAL OF CELL BIOLOGY (2003)

Article Biochemistry & Molecular Biology

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

SS Gill et al.

NATURE MEDICINE (2003)

Review Endocrinology & Metabolism

Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs

V Bruno et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)